Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation

Hsi-Hsien Hsu(Mackay Memorial Hospital), Chih‐Yang Huang(China Medical University)
World Journal of Gastroenterology
January 1, 2017
Cited by 73


Related Papers